Changes in Left Ventricular Structure and Function following Renal Artery Revascularization

Annals of Vascular Surgery

Volumn 24, Issue 1, 2010, Pages 80-84

  Corriere, Matthew A ^a   Hoyle, John R ^a   Craven, Timothy E ^a   D'Agostino Jr , Ralph B ^a   Edwards, Matthew S ^a   Moore, Phillip S ^a   Hansen, Kimberley J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL ARTERY; REVASCULARIZATION; STUDENT T TEST;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; REGISTRIES; RENAL ARTERY OBSTRUCTION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 72249096476     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.05.004     Document Type: Article

References (22)

1. Edwards M.S., Hansen K.J., Craven T.E., et al. Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study. Vasc Endovascular Surg 38 (2004) 25-35
2. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., and Hansen K.J. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 165 (2005) 207-213
3. Johansson M., Herlitz H., Jensen G., Rundqvist B., and Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 17 (1999) 1743-1750
4. Gottdiener J.S., Bednarz J., Devereux R., et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17 (2004) 1086-1119
5. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
6. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
7. Bursi F., Weston S.A., Redfield M.M., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006) 2209-2216
8. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
9. Garovic V.D., and Textor S.C. Renovascular hypertension and ischemic nephropathy. Circulation 112 (2005) 1362-1374
10. Bluemke D.A., Kronmal R.A., Lima J.A., et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52 (2008) 2148-2155
11. de Simone G., Gottdiener J.S., Chinali M., and Maurer M.S. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 29 (2008) 741-747
12. Losito A., Fagugli R.M., Zampi I., et al. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 9 (1996) 1062-1067
13. Wright J.R., Shurrab A.E., Cooper A., Kalra P.R., Foley R.N., and Kalra P.A. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 16 (2005) 2746-2753
14. Yoshihara F., Nishikimi T., Yoshitomi Y., et al. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. Am J Hypertens 9 (1996) 523-528
15. Zeller T., Rastan A., Schwarzwalder U., et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther 14 (2007) 189-197
16. Yoshitomi Y., Nishikimi T., Abe H., et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 27 (1996) 319-323
17. Ruilope L.M., and Schmieder R.E. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 21 (2008) 500-508
18. Mancini G.B., Dahlof B., and Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 109 Suppl. 1 (2004) IV22-IV30
19. Koren M.J., Ulin R.J., Koren A.T., Laragh J.H., and Devereux R.B. Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 15 (2002) 1021-1028
20. Devereux R.B., Wachtell K., Gerdts E., et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292 (2004) 2350-2356
21. Mistry S., Ives N., Harding J., et al. Angioplasty and Stent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens 21 (2007) 511-515
22. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 152 (2006) 59-66